Basic Research - CHDI research contracts with academic institutions provide an allowance for overhead and indirect costs equal to 15% of budgeted personnel and laboratory consumables costs incurred in connection with laboratory research projects. Costs associated with custom-made reagents, animals purchased from third parties, equipment, travel, and per diem expenses are not considered personnel or laboratory consumables costs for purposes of this overhead and indirect costs allowance.

Clinical Research - At the present time, overhead and indirect costs associated with the coordination, data management, biostatistics and site activities of clinical research projects are assessed on a case-by-case basis.

If you have any questions about how this policy affects a CHDI-supported project, please email This e-mail address is being protected from spambots. You need JavaScript enabled to view it .

CHDI research contracts with academic institutions are intended to support the work of faculty members, post-doctoral fellows and associated technical staff. In exceptional circumstances CHDI will consider providing support for graduate students. However, these circumestances must be discussed before a project commences and will be assesed on a case-by-case basis.

If you have any questions about this policy, please send an email to This e-mail address is being protected from spambots. You need JavaScript enabled to view it .

CHDI believes that sharing information will accelerate our goal of finding treatments for Huntington’s disease as quickly as possible and is committed to making such exchanges as easy as possible. Our approach tries to strike a balance between the free exchange of information, researchers’ interest in publication and the creation of desirable intellectual property. The terms of our contracts reflect our attempt to find this balance.

If you have any questions about this policy, please send an email to This e-mail address is being protected from spambots. You need JavaScript enabled to view it .

CHDI prefers to support research rather than meetings at which research results are reported. When we feel a subject requires discussion to further Huntington's disease research, we may organize a workshop or meeting.

We will also consider a meeting collaboration if the proposed meeting might yield insights that accelerate the development of therapies for Huntington’s disease. CHDI will consider supporting an independent meeting if:

• The meeting proposal demonstrates how HD researchers will benefit from the experiences and activities of those working in different fields.
• CHDI has input into the format and the planning of the meeting.
• A written request for support is submitted three months before the meeting.